436 related articles for article (PubMed ID: 26852340)
1. Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents.
Devkota L; Lin CM; Strecker TE; Wang Y; Tidmore JK; Chen Z; Guddneppanavar R; Jelinek CJ; Lopez R; Liu L; Hamel E; Mason RP; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem; 2016 Mar; 24(5):938-956. PubMed ID: 26852340
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy.
Sriram M; Hall JJ; Grohmann NC; Strecker TE; Wootton T; Franken A; Trawick ML; Pinney KG
Bioorg Med Chem; 2008 Sep; 16(17):8161-71. PubMed ID: 18722127
[TBL] [Abstract][Full Text] [Related]
3. Structural interrogation of benzosuberene-based inhibitors of tubulin polymerization.
Herdman CA; Devkota L; Lin CM; Niu H; Strecker TE; Lopez R; Liu L; George CS; Tanpure RP; Hamel E; Chaplin DJ; Mason RP; Trawick ML; Pinney KG
Bioorg Med Chem; 2015 Dec; 23(24):7497-520. PubMed ID: 26775540
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents.
Tanpure RP; George CS; Strecker TE; Devkota L; Tidmore JK; Lin CM; Herdman CA; Macdonough MT; Sriram M; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem; 2013 Dec; 21(24):8019-32. PubMed ID: 24183586
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of structurally diverse 6-aryl-3-aroyl-indole analogues as inhibitors of tubulin polymerization.
Ren W; Deng Y; Ward JD; Vairin R; Bai R; Wanniarachchi HI; Hamal KB; Tankoano PE; Tamminga CS; Bueno LMA; Hamel E; Mason RP; Trawick ML; Pinney KG
Eur J Med Chem; 2024 Jan; 263():115794. PubMed ID: 37984295
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents.
Maguire CJ; Chen Z; Mocharla VP; Sriram M; Strecker TE; Hamel E; Zhou H; Lopez R; Wang Y; Mason RP; Chaplin DJ; Trawick ML; Pinney KG
Medchemcomm; 2018 Oct; 9(10):1649-1662. PubMed ID: 30429970
[TBL] [Abstract][Full Text] [Related]
7. Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization.
Niu H; Strecker TE; Gerberich JL; Campbell JW; Saha D; Mondal D; Hamel E; Chaplin DJ; Mason RP; Trawick ML; Pinney KG
J Med Chem; 2019 Jun; 62(11):5594-5615. PubMed ID: 31059248
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
9. Thiazolidinone Constraint Combretastatin Analogs as Novel Antitubulin Agents: Design, Synthesis, Biological Evaluation and Docking Studies.
Sharma S; Gupta MK; Saxena AK; Bedi PM
Anticancer Agents Med Chem; 2017; 17(2):230-240. PubMed ID: 27141882
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Biological Evaluation of Benzocyclooctene-based and Indene-based Anticancer Agents that Function as Inhibitors of Tubulin Polymerization.
Herdman CA; Strecker TE; Tanpure RP; Chen Z; Winters A; Gerberich J; Liu L; Hamel E; Mason RP; Chaplin DJ; Trawick ML; Pinney KG
Medchemcomm; 2016 Dec; 7(12):2418-2427. PubMed ID: 28217276
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent.
Hadimani MB; Macdonough MT; Ghatak A; Strecker TE; Lopez R; Sriram M; Nguyen BL; Hall JJ; Kessler RJ; Shirali AR; Liu L; Garner CM; Pettit GR; Hamel E; Chaplin DJ; Mason RP; Trawick ML; Pinney KG
J Nat Prod; 2013 Sep; 76(9):1668-78. PubMed ID: 24016002
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a potent microtubule-targeting agent: Synthesis and biological evaluation of water-soluble amino acid prodrug of combretastatin A-4 derivatives.
Yu K; Li R; Yang Z; Wang F; Wu W; Wang X; Nie C; Chen L
Bioorg Med Chem Lett; 2015 Jun; 25(11):2302-7. PubMed ID: 25933592
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents.
Monk KA; Siles R; Hadimani MB; Mugabe BE; Ackley JF; Studerus SW; Edvardsen K; Trawick ML; Garner CM; Rhodes MR; Pettit GR; Pinney KG
Bioorg Med Chem; 2006 May; 14(9):3231-44. PubMed ID: 16442292
[TBL] [Abstract][Full Text] [Related]
14. The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts.
Strecker TE; Odutola SO; Lopez R; Cooper MS; Tidmore JK; Charlton-Sevcik AK; Li L; MacDonough MT; Hadimani MB; Ghatak A; Liu L; Chaplin DJ; Mason RP; Pinney KG; Trawick ML
Cancer Lett; 2015 Dec; 369(1):229-41. PubMed ID: 26325604
[TBL] [Abstract][Full Text] [Related]
15. Combretastatin-based compounds with therapeutic characteristics: a patent review.
Nainwal LM; Alam MM; Shaquiquzzaman M; Marella A; Kamal A
Expert Opin Ther Pat; 2019 Sep; 29(9):703-731. PubMed ID: 31369715
[No Abstract] [Full Text] [Related]
16. Combretastatin dinitrogen-substituted stilbene analogues as tubulin-binding and vascular-disrupting agents.
Siles R; Ackley JF; Hadimani MB; Hall JJ; Mugabe BE; Guddneppanavar R; Monk KA; Chapuis JC; Pettit GR; Chaplin DJ; Edvardsen K; Trawick ML; Garner CM; Pinney KG
J Nat Prod; 2008 Mar; 71(3):313-20. PubMed ID: 18303849
[TBL] [Abstract][Full Text] [Related]
17. Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia.
Winn BA; Devkota L; Kuch B; MacDonough MT; Strecker TE; Wang Y; Shi Z; Gerberich JL; Mondal D; Ramirez AJ; Hamel E; Chaplin DJ; Davis P; Mason RP; Trawick ML; Pinney KG
J Nat Prod; 2020 Apr; 83(4):937-954. PubMed ID: 32196334
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Biological Evaluation of a Novel Water-soluble Prodrug of Docetaxel with Amino Acid as a Linker.
Ma H; Chen G; Wang T; Li Q; Liu Y
Chem Biol Drug Des; 2016 Sep; 88(3):363-9. PubMed ID: 27061863
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of arylcinnamide linked combretastatin-A4 hybrids as tubulin polymerization inhibitors and apoptosis inducing agents.
Kamal A; Bajee S; Lakshma Nayak V; Venkata Subba Rao A; Nagaraju B; Ratna Reddy C; Jeevak Sopanrao K; Alarifi A
Bioorg Med Chem Lett; 2016 Jun; 26(12):2957-2964. PubMed ID: 27161282
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Biological Evaluation, and Molecular Docking of Combretastatin and Colchicine Derivatives and their hCE1-Activated Prodrugs as Antiviral Agents.
Richter M; Boldescu V; Graf D; Streicher F; Dimoglo A; Bartenschlager R; Klein CD
ChemMedChem; 2019 Feb; 14(4):469-483. PubMed ID: 30605241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
